FDA Leader Awaiting Data on Abortion Pill
What: Despite mifepristone’s long safety record, FDA Commissioner Marty Makary says he’s waiting for more data before guaranteeing continued access.
Key Line: “If the data suggests something… we can’t promise we’re not going to act on that data.”
ACOG proposes fewer but longer prenatal visits to improve care for low-risk pregnancies.
Legislators push for regulation and oversight of anti-abortion pregnancy centers.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
JAMA editorial calls for uniform lactation training among healthcare workers.
A former NIH director calls for institutional changes to better prioritize female health.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Young women now outpace young men in binge drinking, a reversal from previous years.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Seventeen GOP-led states aim to dismantle privacy protections for abortion patients; judge questions HIPAA’s constitutionality.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
The 19th highlights how removing “DEI” efforts puts research on women’s health at risk.
A small increase in births among women in their 30s and 40s offsets younger declines.
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
Women who start menopause before age 40 may face faster cognitive decline.
New Yorker review highlights how fetal rights are becoming the next legal front.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.